Effectiveness and Safety of Edaravone Dexborneol in Acute Ischemic Stroke

Thrombolysis Combined With Edaravone Dexborneol on Hemorrhagic Transformation for Acute Ischemic Stroke

NCT05035953 ·Status: UNKNOWN ·Phase: PHASE2

Effect of Early Versus Late Initiation of Edaravone Dexborneol on Neural Function in Patients With Acute Ischemic Stroke

NCT05885919 ·Status: UNKNOWN ·Phase: PHASE3

Edaravone Dexborneol Sublingual Tablet for the PSCI in Acute Ischemic Stroke Patients

NCT06315231 ·Status: RECRUITING ·Phase: PHASE2

Improving Neuroprotective Strategy for Ischemic Stroke With Sufficient Recanalization After Thrombectomy by Edaravone Dexborneol

NCT04667637 ·Status: COMPLETED ·Phase: PHASE2

Treatment of Acute Ischemic STroke With Edaravone Dexborneol II (TASTE-2)

NCT05249920 ·Status: COMPLETED ·Phase: PHASE3

The Efficacy and Safety of Edaravone Dexborneol Sequential Therapy in the Treatment of Patients With AIS

NCT06176781 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

Edaravone Dexborneol Combining With Mechanical Thrombectomy in the Treatment of Acute Ischemic Stroke

NCT05121883 ·Status: UNKNOWN

Study of Compound Edaravone Injection for Treatment of Acute Ischemic Stroke

NCT02430350 ·Status: COMPLETED ·Phase: PHASE3

Treatment of Acute Ischemic Stroke With Rt-PA Combined With Edaravone Dexborneol

NCT06248242 ·Status: RECRUITING ·Phase: PHASE4

Efficacy and Safety Study of Ultra-early Mobile Stroke Unit Neuroprotection Combined With Revascularization for Acute Ischemic Stroke (EXCELLENT)

NCT07119021 ·Status: RECRUITING ·Phase: PHASE4

Compound Edaravone Injection for Acute Ischemic Stroke

NCT01929096 ·Status: COMPLETED ·Phase: PHASE2

Clinical Comprehensive Evaluation of Neuroprotective Drugs for Acute Ischemic Stroke

NCT07260760 ·Status: NOT_YET_RECRUITING

Edaravone Dexborneol for Treatment of Hypertensive Intracerebral Hemorrhage

NCT04714177 ·Status: UNKNOWN ·Phase: PHASE2

A Clinical Trial of Danhong Injection in Treating Acute Ischemic Stroke

NCT02152280 ·Status: UNKNOWN ·Phase: PHASE4

Comparative Effectiveness of Neuroprotectants on Acute Ischemic Stroke

NCT01556854 ·Status: UNKNOWN

Using Real-world Evidence to Analyze the Clinical Effects and Adverse Events of Butylphthalide in Stroke Patients

NCT05086874 ·Status: COMPLETED

Study on the Effectiveness and Safety of Shuxinin Injection in the Treatment of Acute Ischemic Stroke

NCT04950790 ·Status: UNKNOWN ·Phase: PHASE4

Study of Compound Edaravone Injection for Treatment of Acute Ischemic Stroke

NCT04984577 ·Status: SUSPENDED ·Phase: PHASE2

Evaluate the Efficacy and Safety of Different Doses of Edaravone Dexborneol Concentrated Solution for Injection Combined With Conventional Medical Therapy in the Treatment of Patients With Cerebral Hemorrhage

NCT05953103 ·Status: TERMINATED ·Phase: PHASE2

Dengzhanxixin Injection for Acute Ischemic Stroke Receiving Reperfusion Therapy

NCT05700097 ·Status: UNKNOWN ·Phase: PHASE2

Efficacy and Safety of Human Urinary Kallidinogenase Combined With Endovascular Therapy in Acute Ischemic Stroke With Large Vessel Occlusion

NCT06211712 ·Status: RECRUITING ·Phase: NA

Efficacy and Safety of LT3001 on Treating the Acute Ischemic Stroke

NCT05686642 ·Status: RECRUITING ·Phase: PHASE2

Efficacy and Safety of Tenecteplase Intravenous Thrombolysis in Acute Posterior Circulation Ischemic Stroke Within 4.5-24 Hours After Onset

NCT07094763 ·Status: NOT_YET_RECRUITING ·Phase: NA

Endovascular Therapy for Acute Ischemic Stroke Trial

NCT02350283 ·Status: COMPLETED ·Phase: PHASE3

Effectiveness of Yangxue Qingnao Granules in Preventing Post Thrombolytic Hemorrhage Transformation in Patients With Acute Cerebral Infarction

NCT06344312 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA